Healthcare -
Biotechnology - NASDAQ - US
$ 13.49
-0.369 %
$ 195 M
Market Cap
0.11
P/E
INBX - OPERATING INCOME
Operating Income INBX - Inhibrx Biosciences, Inc.
-219 M
LAST VALUE
-69.21%
2 YEAR CAGR
-49.34%
5 YEAR CAGR
0.00%
10 YEAR CAGR